These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26125413)

  • 1. Apolipoprotein A-I mimetic peptide reverses impaired arterial healing after injury by reducing oxidative stress.
    Rosenbaum MA; Chaudhuri P; Abelson B; Cross BN; Graham LM
    Atherosclerosis; 2015 Aug; 241(2):709-15. PubMed ID: 26125413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The apolipoprotein A-I mimetic peptide, D-4F, alleviates ox-LDL-induced oxidative stress and promotes endothelial repair through the eNOS/HO-1 pathway.
    Liu D; Ding Z; Wu M; Xu W; Qian M; Du Q; Zhang L; Cui Y; Zheng J; Chang H; Huang C; Lin D; Wang Y
    J Mol Cell Cardiol; 2017 Apr; 105():77-88. PubMed ID: 28274624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercholesterolemia and oxidative stress inhibit endothelial cell healing after arterial injury.
    Rosenbaum MA; Miyazaki K; Graham LM
    J Vasc Surg; 2012 Feb; 55(2):489-96. PubMed ID: 22047834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor-null and LDL receptor/apolipoprotein A-I double-knockout mice on Western diet.
    Ou J; Wang J; Xu H; Ou Z; Sorci-Thomas MG; Jones DW; Signorino P; Densmore JC; Kaul S; Oldham KT; Pritchard KA
    Circ Res; 2005 Nov; 97(11):1190-7. PubMed ID: 16224061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercholesterolemia inhibits re-endothelialization of arterial injuries by TRPC channel activation.
    Rosenbaum MA; Chaudhuri P; Graham LM
    J Vasc Surg; 2015 Oct; 62(4):1040-1047.e2. PubMed ID: 24820897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease.
    Ou J; Ou Z; Jones DW; Holzhauer S; Hatoum OA; Ackerman AW; Weihrauch DW; Gutterman DD; Guice K; Oldham KT; Hillery CA; Pritchard KA
    Circulation; 2003 May; 107(18):2337-41. PubMed ID: 12732610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein A-1 mimetic peptide 4F promotes endothelial repairing and compromises reendothelialization impaired by oxidized HDL through SR-B1.
    He D; Zhao M; Wu C; Zhang W; Niu C; Yu B; Jin J; Ji L; Willard B; Mathew AV; Chen YE; Pennathur S; Yin H; He Y; Pan B; Zheng L
    Redox Biol; 2018 May; 15():228-242. PubMed ID: 29277016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis.
    Sherman CB; Peterson SJ; Frishman WH
    Cardiol Rev; 2010; 18(3):141-7. PubMed ID: 20395699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of D-4F on vasodilation, oxidative stress, angiostatin, myocardial inflammation, and angiogenic potential in tight-skin mice.
    Weihrauch D; Xu H; Shi Y; Wang J; Brien J; Jones DW; Kaul S; Komorowski RA; Csuka ME; Oldham KT; Pritchard KA
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1432-41. PubMed ID: 17496220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR-Based Metabolomic Analysis on the Protective Effects of Apolipoprotein A-I Mimetic Peptide against Contrast Media-Induced Endothelial Dysfunction.
    Jiang T; Du Q; Huang C; Xu W; Guo P; Li W; Xie X; Guo Y; Liu D; Lin D
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties.
    Wool GD; Reardon CA; Getz GS
    J Lipid Res; 2008 Jun; 49(6):1268-83. PubMed ID: 18323574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage.
    White CR; Datta G; Wilson L; Palgunachari MN; Anantharamaiah GM
    Chem Phys Lipids; 2019 Mar; 219():28-35. PubMed ID: 30707910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes.
    Kruger AL; Peterson S; Turkseven S; Kaminski PM; Zhang FF; Quan S; Wolin MS; Abraham NG
    Circulation; 2005 Jun; 111(23):3126-34. PubMed ID: 15939814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein A-I mimetic peptides.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Yu N; Ansell BJ; Datta G; Garber DW; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1325-31. PubMed ID: 15831812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein-AI mimetic peptides D-4F and L-5F decrease hepatic inflammation and increase insulin sensitivity in C57BL/6 mice.
    McGrath KC; Li X; Twigg SM; Heather AK
    PLoS One; 2020; 15(1):e0226931. PubMed ID: 31914125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties.
    Nguyen SD; Maaninka K; Lappalainen J; Nurmi K; Metso J; Öörni K; Navab M; Fogelman AM; Jauhiainen M; Lee-Rueckert M; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):274-84. PubMed ID: 26681753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse apolipoprotein A-I mimetic peptide R-D4F inhibits neointimal formation following carotid artery ligation in mice.
    Du L; Qu X; Zheng H; Li R; Wang J; Chen M; Zhao P; Zhang Z; Gong K
    Am J Pathol; 2013 May; 182(5):1932-9. PubMed ID: 23499549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
    Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A-I mimetic peptide inhibits atherosclerosis by altering plasma metabolites in hypercholesterolemia.
    Ou ZJ; Li L; Liao XL; Wang YM; Hu XX; Zhang QL; Wang ZP; Yu H; Zhang X; Hu P; Xu YQ; Liang QL; Ou JS; Luo G
    Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E683-94. PubMed ID: 22535745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide.
    Van Lenten BJ; Wagner AC; Anantharamaiah GM; Garber DW; Fishbein MC; Adhikary L; Nayak DP; Hama S; Navab M; Fogelman AM
    Circulation; 2002 Aug; 106(9):1127-32. PubMed ID: 12196340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.